Values as of: 2024-10-04
COMMON STOCK | Specialty Chemicals |
Last Closing
USD 69.5Change
0.00 (0.00)%Market Cap
USD 33.18BVolume
400.00Analyst Target
N/AVerdict
Verdict
Novonesis A/S produces and sells industrial enzymes, microorganisms, and probiotics in Denmark, rest of Europe, North America, Asia Pacific, the Middle East, Africa, Latin America, and internationally. The company offers protein solutions for the food and beverage industry. It also offers industrial hygiene, drain openers, hard surface, medical cleaning, septic tanks, ware washing, and professional laundry services. In addition, the company provides dishwashing, softener, microbial and medical cleaning services. Further, it provides corn, cotton, forages, peanuts, pulses, soybeans, wheat, small grains, bioyield, and biocontrol solutions; warm water species, recirculating aquaculture system; animal health and nutrition solutions; fiber modification, bleach boosting, deposit control, and starch modification solutions. Additionally, the company provides carbon capture, leather and textiles solutions; enzyme solutions, including corn and wheat separation, liquefaction, saccharification, filtration, isomerization, maltose, and specialties solutions; warm water species and recirculating aquaculture system solutions; human health solutions, comprising brain, oral, protective and immune, and gastrointestinal health solutions; ethanol, biodiesel, renewable diesel, education, wastewater, and sewage sludge, and renewable diesel solutions; agriculture and industry, biogas food waste, food waste, biocatalysis, cell culture, diagnostics, enzyme, and biogas solutions. Furthermore, it provides lipases, proteases, oxidoreductases, and carbohydrases. Novonesis A/S was founded in 1925 and is based in Bagsvaerd, Denmark.
Company Website : https://www.novonesis.com
Currency: USD
Country : USA
| Symbol | Name | Price(Change) | Market Cap |
|---|---|---|---|
| AIQUY | Air Liquide SA ADR |
+0.06 (+0.16%) |
USD 112.91B |
| AIQUF | L'Air Liquide S.A |
-6.86 (-3.62%) |
USD 112.79B |
| NDEKF | Nitto Denko Corporation |
N/A |
USD 62.82B |
| NDEKY | Nitto Denko Corp |
-0.47 (-2.79%) |
USD 62.43B |
| SXYAY | Sika AG ADR |
N/A |
USD 53.52B |
| SKFOF | Sika AG |
-15.05 (-4.70%) |
USD 53.38B |
| GVDNY | Givaudan SA ADR |
N/A |
USD 50.45B |
| GVDBF | Givaudan SA |
+75.50 (+1.50%) |
USD 47.79B |
| DSMFF | DSM-Firmenich AG |
N/A |
USD 36.04B |
| EMSHF | EMS-CHEMIE HOLDING AG |
N/A |
USD 19.50B |
| Market Performance vs. Industry/Classification (Specialty Chemicals) | Market Performance vs. Exchange | ||||||
| Value | Sector Median | Percentile Rank | Grade | Market Median | Percentile Rank | Grade | |
| YTD | |||||||
| Capital Gain | 26.39% | 84% | B | 76% | C+ | ||
| Dividend Return | 0.52% | 12% | F | 8% | B- | ||
| Total Return | 26.91% | 82% | B | 74% | C | ||
| Trailing 12 Months | |||||||
| Capital Gain | 64.46% | 89% | A- | 86% | B+ | ||
| Dividend Return | 0.68% | 16% | F | 14% | F | ||
| Total Return | 65.14% | 87% | B+ | 86% | B+ | ||
| Trailing 5 Years | |||||||
| Capital Gain | 64.96% | 87% | B+ | 81% | B- | ||
| Dividend Return | 17.81% | 71% | C- | 56% | F | ||
| Total Return | 82.77% | 84% | B | 81% | B- | ||
| Average Annual (5 Year Horizon) | |||||||
| Capital Gain | 4.46% | N/A | N/A | 47% | F | ||
| Dividend Return | 7.19% | N/A | N/A | 47% | F | ||
| Total Return | 2.72% | N/A | N/A | 52% | F | ||
| Risk Return Profile | |||||||
| Volatility (Standard Deviation) | 25.17% | N/A | N/A | 79% | B- | ||
| Risk Adjusted Return | 28.55% | N/A | N/A | 64% | D | ||
| Market Capitalization | 33.18B | 90% | A- | 97% | N/A | ||
| Target Price Action | Rating Action | Analyst | Rating | Price | Date |
|---|
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
The company had positive total cash flow in the most recent four quarters.
The company had positive total free cash flow in the most recent four quarters.
This stock has shown top quartile dividend growth in the previous 5 years compared to its sector
This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
The stock is trading high compared to its peers median on a price to book value basis.
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
